<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR35">
 <label>35.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gaspari</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Zengarini</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Greco</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Vangeli</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Mastroianni</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>Side effects of ruxolitinib in patients with SARS-CoV-2 infection: two case reports</article-title>
  <source>Int J Antimicrob Agents</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.106023</pub-id>
  <?supplied-pmid 32450201?>
  <pub-id pub-id-type="pmid">32450201</pub-id>
 </element-citation>
</ref>
